首页>
外国专利>
PREDICTION OF BREAST CANCER RESPONSE TO TAXANE-BASED CHEMOTHERAPY
PREDICTION OF BREAST CANCER RESPONSE TO TAXANE-BASED CHEMOTHERAPY
展开▼
机译:预测乳腺癌对基于TAXANE的化学疗法的反应
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to methods and kits for the prediction of a likely outcome of chemotherapy in a cancer patient. More specifically, the invention relates to the prediction of tumour response to chemotherapy based on measurements of expression levels of a small set of marker genes. The set of marker genes is useful for the identification of breast cancer subtypes responsive to taxane based chemotherapy, such as e.g. a taxane-anthracycline-cyclophosphamide-based (e.g. Taxotere (docetaxel)- Adriamycin (doxorubicin)-cyclophosphamide, i.e. (TAC)-based) chemotherapy.
展开▼